Leukeran
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Leukeran, covering 2010-04-23 to 2022-03-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 3]